Symbols

BLRX

BioLineRx·NASDAQ

--(--)

BLRX Filings

2026-03-26 · Key Events

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

2026-03-23 · Earnings Call

BioLineRx Ltd. (BLRX) Q4 2025 Earnings Call Transcript

2026-03-23 · Financials

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

2026-03-23 · Financials

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

2026-03-18 · Ownership

Form 3 - Initial statement of beneficial ownership of securities

2026-03-18 · Ownership

Form 3 - Initial statement of beneficial ownership of securities

2026-02-23 · Key Events

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

2026-01-23 · Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans

2025-11-24 · Earnings Call

BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript

2025-11-24 · Financials

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]